NASDAQ: CLVS       Clovis Oncology Inc
Last Price Today's Change   Day's Range   Trading Volume
6.38   -0.26 (3.92%)  6.07 - 6.735  4,655,100


Avg Volume (4 weeks):5,613,216
4 Weeks Range:4.41 - 6.74
4 Weeks Price Volatility (%):
52 Weeks Range:3.62 - 11.63
52 Weeks Price Volatility (%):
Average Price Target: 26.50
Price Target Upside/Downside: +20.12


No recent Headlines for this stock.

Business Background

Clovis Oncology Inc is operative in the healthcare sector based in the United States. As a pharmaceutical manufacturer, it is focused on developing and commercializing anti-cancer agents. Its suite of product candidates includes Rociletinib, Rucaparib and Lucitanib. Rociletinib is an oral epidermal growth factor receptor (EGFR), mutant-selective covalent inhibitor for the treatment of non-small cell lung cancer. Rucaparib is an oral inhibitor of poly (ADP-ribose) polymerase (PARP) that is in advanced clinical development for the treatment of ovarian cancer. The company's revenue primarily depends on the sale of Rucaparib in the United States market.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3417  5658  500  79 

Top 10 Active Counters
 CTRM 0.43+0.08 
 NAKD 0.45-0.10 
 F 11.53+0.25 
 ACST 0.83-0.09 
 BBIG 4.56-1.41 
 CLSN 1.74-0.67 
 SNDL 0.661-0.016 
 ADTX 3.80+0.70 
 AAPL 136.87+3.07 
 QTT 4.34+0.81